Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 57.52B | 56.04B | 55.05B | 49.85B | 42.48B |
Gross Profit | 11.14B | 9.73B | 9.94B | 9.77B | 7.54B |
EBITDA | 5.35B | 4.09B | 4.28B | 5.46B | 3.81B |
Net Income | 1.19B | 342.00M | -257.00M | 2.35B | 1.05B |
Balance Sheet | |||||
Total Assets | 77.80B | 79.12B | 73.03B | 71.49B | 67.91B |
Cash, Cash Equivalents and Short-Term Investments | 8.71B | 8.28B | 8.29B | 11.52B | 12.75B |
Total Debt | 24.59B | 25.58B | 24.88B | 25.06B | 25.64B |
Total Liabilities | 41.01B | 42.44B | 40.75B | 40.24B | 38.81B |
Stockholders Equity | 30.72B | 31.16B | 26.89B | 26.42B | 22.99B |
Cash Flow | |||||
Free Cash Flow | 954.00M | -1.47B | -1.83B | 811.00M | 1.09B |
Operating Cash Flow | 4.64B | 2.78B | 2.23B | 4.06B | 3.57B |
Investing Cash Flow | -2.81B | -2.84B | -4.48B | -3.34B | -2.47B |
Financing Cash Flow | -1.70B | -241.00M | -1.38B | -2.12B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥19.53B | 11.14 | 1.87% | 27.72% | 70.12% | ||
79 Outperform | ¥14.33B | 14.99 | 1.90% | 2.44% | 163.48% | ||
76 Outperform | ¥15.71B | 16.50 | 2.05% | 33.05% | ― | ||
71 Outperform | ¥14.17B | 4.84 | 3.30% | -6.23% | 405.48% | ||
66 Neutral | £2.67B | 12.98 | 3.30% | 3.25% | 2.40% | -23.01% | |
60 Neutral | ¥14.87B | 16.16 | 1.67% | 29.02% | ― | ||
54 Neutral | ¥13.60B | ― | 5.28% | -1.14% | 68.17% |